Michigan attorney tipped family about pharmaceutical companies' merger, SEC says
Why now
Thesis: Insider-trading enforcement around pharma deal
Catalyst to watch: SEC case developments
Main risk: Case details remain unproven allegations
Why it matters
An insider-tipping case around a pharma merger highlights enforcement risk in deal-related trading.
Related assets & topics
HealthcareInsider TradingSources
- googlenews · news.google.com · 2026-09-28 14:20 UTC